Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic LeukemiaDeepa Bhojwani, Mary V. Relling, Sima Jeha et al.|Journal of Clinical Oncology|2014Cited by 390
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical EffectsLisa R. Treviño, Mary V. Relling, Noriko Shimasaki et al.|Journal of Clinical Oncology|2009Cited by 352
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaJitesh D. Kawedia, Mary V. Relling, Sue C. Kaste et al.|Blood|2010Cited by 259
Genome-wide study of methotrexate clearance replicates SLCO1B1Laura B. Ramsey, Mary V. Relling, John C. Panetta et al.|Blood|2012Cited by 213
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsSteven W. Paugh, William E. Evans, Erik Bonten et al.|Nature Genetics|2015Cited by 162